The β3-integrin endothelial adhesome regulates microtubule dependent cell migration
Integrin {beta}3 is seen as a key anti-angiogenic target for cancer treatment due to its expression on neovasculature, but the role it plays in the process is complex; whether it is pro- or anti-angiogenic depends on the context in which it is expressed. To understand precisely {beta}3s role in regulating integrin adhesion complexes in endothelial cells, we characterised, by mass spectrometry, the {beta}3- dependent adhesome. We show that depletion of {beta}3-integrin in this cell type leads to changes in microtubule behaviour that control their migration. {beta}3- integrin regulates microtubule stability in endothelial cells through Rcc2/Anxa2 driven control of Rac1 activity. Our findings reveal that angiogenic processes, both in vitro and in vivo, are more sensitive to microtubule targeting agents when {beta}3-integrin levels are reduced.